Gaudi Clinical
PrivateLast Round
Series A
Feb 7, 2025
Est. Valuation
$23.7M
Total Funding Raised
$20.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Gaudi Clinical operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series A round in February 2025.
Gaudi Clinical is a healthcare company that provides a platform for regenerative medicine, offering cell culture processing services and regulatory compliance support for medical institutions in the orthopedic and dental fields.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gaudi Clinical Comparables
Compare Gaudi Clinical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellBank Corp. | 84% | |
| Biotherapy Institute of Japan, Inc. | 80% | |
| CellSource Co., Ltd. | 77% |
For institutional investors. Book with your work email.
Gaudi Clinical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 7, 2025 | ||||
| Series A | Feb 7, 2024 | ||||
| Debt | Jul 3, 2023 | ||||
| Seed | Nov 22, 2022 |
For institutional investors. Book with your work email.
Gaudi Clinical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAFCO Group Co., Ltd. | Series A, Seed |
| Mizuho Capital | Series A |
| 株式会社日本政策金融公庫 | Debt |
| Shizuoka Capital | Series A |
| Mitsui Sumitomo Insurance | Series A |
| JIC Venture Growth Investments | Series A |
| Samurai Incubate Inc. | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2026
Open roles increased to 3, representing 75% of headcount.
- Sep 21, 2026
Open roles increased to 3, representing 75% of headcount.
For institutional investors. Book with your work email.
Gaudi Clinical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gaudi Clinical's valuation, stock price, and market status.
Is Gaudi Clinical a public or private company?
Gaudi Clinical is a private company.
What is the current stock price of Gaudi Clinical?
Gaudi Clinical is a private company, so its shares have no public market price. Caplight tracks Gaudi Clinical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gaudi Clinical worth (valuation)?
Gaudi Clinical's valuation is estimated at $23.7M based on funding round data.
Can I buy Gaudi Clinical stock?
Gaudi Clinical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gaudi Clinical's last funding round?
Gaudi Clinical's most recent funding round was Series A on February 7, 2025.
Who are the main investors in Gaudi Clinical?
Key investors in Gaudi Clinical include JAFCO Group Co., Ltd., 株式会社日本政策金融公庫, JIC Venture Growth Investments.
Will Gaudi Clinical IPO soon?
No public IPO plans have been announced for Gaudi Clinical.
How can I track Gaudi Clinical secondary market activity?
Caplight tracks bids, offers, and trades in Gaudi Clinical's shares on secondary markets.